Bioweapons and bioterrorism: A review of history and biological agents

Defence S and T Technical Bulletin

Volumn 6, Issue 2, 2013, Pages 111-129

  Cenciarelli, Orlando ^a   Rea, Silvia ^a   Carestia, Mariachiara ^a   D'Amico, Fabrizio ^a   Malizia, Andrea ^a   Bellecci, Carlo ^a   Gaudio, Pasquale ^a   Gucciardino, Antonio ^a   Fiorito, Roberto ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Biological agents and toxins; Biosafety level (BSL); Bioterrorism; Bioweapons; Fatality rates

Indexed keywords

EID: 84892447426     PISSN: 19856571     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Acheson, N.H. (2011). Fundamentals of Molecular Virology. Wiley, New York.
2. Adams, M..J. & Carstens, E.B. (2012). Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses. Arch. Virol. 157:1411-1422.
3. Aldhous P. (1990). Biological warfare: Gruinard Island handed back. Nature, 344:801.
4. Arnon, S.S., Schechter, R., Inglesby, T.V., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Fine, A.D., Hauer, J., Layton, M., Lillibridge, S., Osterholm, M.T., O'Toole, T., Parker, G., Perl, T.M., Russell, P.K., Swerdlow, D.L. & Tonat, K. (2001). Botulinum toxin as a biological weapon: medical and public health management. JAMA, 285:1059-1070.
5. Bente, D., Gren, J., Strong, J.E. & Feldmann, H. (2009). Disease modeling for Ebola and Marburg viruses. Dis. Model. Mech. 2:12-17.
6. Bhalla, D.K. & Warheit, D.B. (2004). Biological agents with potential for misuse: a historical perspective and defensive measures. Toxicol Appl Pharmacol., 199:71-84.
7. Bhalla, D.K. & Warheith, D.B. (2004). Biological agents with potential for misuse: ahistorical perspective and defense measures. Toxicol. Appl. Pharm., 199:71-84.
8. Brauburger, K., Hume, A.J., Mühlberger, E. & Olejnik, J. (2012). Forty-five years of Marburg virus research. Viruses, 4:1878-1927.
9. Buchmeier, M.J., de la Torre J.-C. & Peters C.J. (2007). Arenaviridae: The Viruses and Their Replication. In: Knipe D.M. and Howley P.M. (Eds.), Fields Virology. Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 1791-1827.
10. Briese, T., Paweska, J.T., McMullan, L.K., Hutchison, S.K., Street, C., Palacios, G., Khristova, M.L., Weyer, J., Swanepoel, R., Egholm, M., Nichol, S.T. & Lipkin, W.I. (2009). Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog. 5: e1000455.
11. Burri, D.J., da Palma, J.R., Kunz, S. & Pasquato A. (2012). Envelope glycoprotein of arenaviruses. Viruses, 17: 2162-2181.
12. Centers for Diseases Control and Prevention (CDC). Bioterrorism Agents / Diseases. Available online at: http://www.bt.cdc.gov/agent/agentlist-category.asp (Last access date: 8 September 2013).
13. Charrel, R.N. & de Lamballerie, X. (2003). Arenaviruses other than Lassa virus. Antiviral Res., 57: 89-100.
14. Christopher, G.W., Cieslak, T.J., Pavlin J.A. & Eitzen, E.M. (1997). Biological warfare: a historical perspective. JAMA, 278: 412-417.
15. Clark, D.V., Jahrling, P.B. & Lawler, J.V. (2012). Clinical management of filovirusinfected patients. Viruses, 4:1668-1686.
16. Clarke, R. (1968). The Silent Weapons. David McKay Co. New York.
17. Cronin, A.K. (2004). Terrorist motivations for chemical and biological weapons use: Placing the threat in context. Defense Secur. Anal., 20:313-320.
18. DaSilva, E. (1999). Biological warfare, bioterrorism, biodefence and toxin weapons convention. EJB, 2:99-129.
19. Davis, C.J. (1999). Nuclear blindness: An overview of the biological weapons programs of the former Soviet Union and Iraq. Emerg. Infect. Dis., 5: 509- 512.
20. Dembek, Z.F. (2006). The history and threat of biological weapons and bioterrorism. In McIsaac J.H. (ed.), Hospital Preparation for Bioterror: A Medical and Biomedical Systems Approach. Elsevier, London.
21. Dennis, D.T., Inglesby, T.V., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Fine, A.D., Friedlander, A.M., Hauer, J., Layton, M., Lillibridge, S.R., McDade, J.E., Osterholm, M.T., O'Toole, T., Parker, G., Perl, T.M., Russell, P.K. & Tonat, K. (2001). Tularemia as a biological weapon - Medical and public health management. JAMA, 285: 2763-2773.
22. Department of Health and Human Services (DHHS) (2009). Biosafety in Microbiological and Biomedical Laboratories, 5th ed. U.S. Department of Health and Human Services (DHHS), Washington, D.C.
23. Department of Health and Human Services (DHHS) (2010). Ebola Hemorrhagic Fever Information Packet. U.S. Department of Health and Human Services (DHHS), Washington, D.C.
24. Eitzen, E.M. (1997). Use of biological weapons. In Zajtchuk, R. & Bellamy, R.F. (Eds.), Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. Office of the Surgeon General. U.S. Department of the Army, Washington. D.C., pp. 437-450.
25. Fenner, F., Henderson, D.A., Jezek, A. & Ladnyi, I.D. (2007) Smallpox and Its Eradication. World Health Organization (WHO), Geneva, Switzerland.
26. Harris, S. (2002). Factories of Death: Japanese Biological Warfare, 1932-1945, and the American Cover-Up. Routledge, London.
27. Hugh-Hones, M. (1992). Wickham Steed and German biological warfare research. Intell. Nat. Secur., 7:379-402.
28. Knipe, D.M., Howley, P.M., Esposito, J.J. & Fenner, F. (2001). Poxviruses. In: Knipe D.M. and Howley P.M. (Eds.), Fields Virology. Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 2885-2921.
29. Kortepeter, M.G. & Parker, G.W. (1999). Potential biological weapons threats. Emerg. Infect. Dis. 5:523- 527.
30. Kuhn J.H., Dodd, L.E., Wahl-Jensen, V., Radoshitzky, S.R., Bavari, S. & Jahrling, P.B. (2011). Evaluation of perceived threat differences posed by filovirus variants. Biosecur. Bioterror. 9:361-371.
31. La Placa, M. (2010). Principles of Medical Microbiology. Esculapio, Lahore.
32. Leitenberg, M. (2001). Biological weapons in twentieth century: A review and analysis. Crit. Rev. Microbiol., 27: 267-320.
33. Manchee, R.J., Broster, M.G., Melling, J., Henstridge, R.M. & Stagg A.J. (1981). Bacillus anthracis on Gruinard Island. Nature, 294:254-255.
34. McCarthy, M. (2001). Anthrax attack in the USA. Lancet Infect. Dis. 1:288-289.
35. Moss, B. (2007). Poxviridae: The viruses and their replication. In: Knipe D.M. and Howley P.M. (Eds.), Fields Virology. Lippincott Williams & Wilkins, Philadelphia, Pennsylvania, pp. 2905-2946.
36. Newark, T. (1988). Medieval Warfare. Bloomsbury Bools, London. North Atlantic Treaty Organization (NATO) (1996). NATO Handbook on the Medical Aspects of NBC Defensive Operations AMedP-6(B). Part II - Biological. U.S. Department of the Army, Washington DC.
37. Olson, K.B. (1999). Aum Shinrikyo: Once and future threat? Emerg. Infect. Dis., 5: 513-516.
38. Poupard, J.A. & Miller, L.A. (1992). History of biological warfare: Catapults to capsomers. Ann. N. Y. Aca. Sci., 666: 9-20.
39. World Health Organization (WHO) (2004). Public Health Response to Biological and Chemical Weapons. World Health Organization (WHO), Geneva.
40. Rimoin, A.W., Mulembakani, P.M., Johnston, S.C., Lloyd Smith, J.O., Kisalu, N.K., Kinkela, T.L., Blumberg, S., Thomassen, H.A., Pike, B.L., Fair, J.N., Wolfe, N.D., Shongo, R.L., Graham, B.S., Formenty, P., Okitolonda, E., Hensley, L.E., Meyer, H., Wright, L.L. and Muyembe, J.J. (2010). Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci USA, 107:16262-16267.
41. Salvato, M.S., Clegg, J.C.S., Buchmeier, M.J., Charrel, R.N., Gonzalez, J.P., Lukashevich, I.S., Peters, C.J. & Romanowski, V. (2011). Arenaviridae. In King, A.M.Q., Adams, M.J., Carstens, E.B., and Lefkowitz, E.J. (Eds). Virus Taxonomy Classification and Nomenclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier-Academic Press, Oxford, pp. 715-724.
42. Sanchez, A., Geisbert, T.W. & Feldmann, H. (2007). Filoviridae: Marburg and Ebola Viruses. In Knipe D.M. and Howley P.M. (Eds.), Fields Virology. Lippincott Williams & Wilkins, Philadelphia, Pennsylvania, pp. 1409-48.
43. Schattner, M., Rivadeneyra, L., Pozner, R.G. & Gómez, R.M. (2013). Pathogenic mechanisms involved in the hematological alterations of arenavirus-induced hemorrhagic fevers. Viruses, 5:340-351.
44. Sokolski, H.D. & James M. Ludes. (2001). Twenty-First Century Weapons Proliferation. Routledge, London.
45. Stochkholm International Peace Research Institute (SIPRI) (1971a). The Problem of Chemical and Biological Warfare, Vol. 1: The Rise of CB Weapons. Humanity Press. New York.
46. Stochkholm International Peace Research Institute (SIPRI) (1971b). The Problem of Chemical and Biological Warfare, Vol. 2: Technical Aspects of Early Warning and Verification. Humanity Press. New York.
47. Stochkholm International Peace Research Institute (SIPRI) (1973). The Problem of Chemical and Biological Warfare, Vol. 3: CBW and the Law of War. Humanity Press. New York.
48. Török, T.J., Tauxe, R.V., Wise, R.P., Livengood, J.R., Sokolow, R., Mauvais, S., Birkness, K.A., Skeels, M.R., Horan J.M. & Foster L.R. (1997). A large community outbreak of Salmonellosis caused by intentional contamination of restaurant salad bars. JAMA, 278: 389-395.
49. Tucker, J.B. (2013). The current bioweapons threat. In Hunger, I., Radosavljevic, V., Belojevic, G. & Rotz, L.D. (Eds.), Biopreparedness and Public Health. Springer, Amsterdam, pp. 7-16.
50. Vela, E. (2012). Animal models, prophylaxis, and therapeutics for arenavirus infections. Viruses, 4:1802-1829.
51. Vogel, K.M. (2012). Phantom Menace or Looming Danger: A New Framework for Assessing Bioweapons Threats. JHU Press, New York.
52. Warfield, K.L., Swenson, D.L., Demmin, G., & Bavari, S. (2005). Filovirus-like particles as vaccines and discovery tools. Expert Rev. Vaccines, 4:429-440.
53. Weber, D.J. & Rutala, W.A. (2001). Risks and prevention of nosocomial transmission of rare zoonotic diseases. Clin Infect Dis., 32:446-456.
54. Weelis, M. (2002). Biological warfare at the 1346 siege of Caffa. Emerg. Infect. Dis., 8: 971-975.
55. World Health Organization (WHO) (2004). Public Health Response to Biological and Chemical Weapons. World Health Organization (WHO), Geneva, Switzerland.
56. World Health Organization (WHO) (2007). WHO Guidelines on Tularaemia. World Health Organization (WHO), Geneva, Switzerland.
57. Yuen, E.C.P. (2001). Biological warfare: The facts. Hong Kong J. of Emerg. Med. 8:232-240.
58. Zalini, Y. (2010). Combating and reducing the risk of biological threats. J. Defence Secur., 1: 1-15.